Related Experiment Video
Updated: Jan 25, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone
Andrea Salzano1, Roberta D'Assante2, Mark Lander3
1Department of Cardiovascular Sciences, NIHR Leicester Biomedical Research Centre, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK; Department of Translational Medical Sciences, Federico II University, Via Pansini 5, Naples 80138, Italy.
Insights
Heart failure (HF) may stem from multiple hormone deficiencies, particularly growth hormone and testosterone. Hormone replacement therapy offers a promising, innovative treatment approach for improving cardiovascular outcomes in HF patients.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Heart failure (HF) is increasingly viewed as a syndrome involving multiple hormone deficiencies.
- Anabolic hormone deficiencies are common in HF and linked to poor cardiovascular performance and outcomes.
- Growth hormone and testosterone deficiencies are particularly significant in HF pathophysiology.
Purpose of the Study:
- To review the current evidence on growth hormone and testosterone deficiencies in heart failure.
- To explore the role of these deficiencies in cardiovascular performance and patient outcomes.
- To discuss novel findings regarding hormone replacement therapy as a treatment for HF.
Main Methods:
- Systematic review of existing literature on hormone deficiencies in HF.
- Analysis of studies investigating the impact of hormone deficiencies on cardiovascular outcomes.
- Evaluation of evidence for hormone replacement therapies in HF patients.
Main Results:
- Deficiencies in anabolic hormone axes are prevalent in HF patients.
- These deficiencies correlate strongly with diminished cardiovascular function and adverse outcomes.
- Hormone replacement therapy shows potential as an innovative treatment strategy.
Conclusions:
- Heart failure can be conceptualized as a multiple hormone deficiency syndrome.
- Addressing growth hormone and testosterone deficiencies is crucial for managing HF.
- Hormone replacement therapy warrants consideration as a novel therapeutic option in HF.
Abstract:
A growing body of evidence led to the hypothesis that heart failure (HF) could be considered a multiple hormone deficiency syndrome. Deficiencies in the main anabolic axes cannot be considered as mere epiphenomena, are very common in HF, and are clearly associated with poor cardiovascular performance and outcomes. Growth hormone deficiency and testosterone deficiency play a pivotal role and the replacement treatment is an innovative therapy that should be considered. This article appraises the current evidence regarding growth hormone and testosterone deficiencies in HF and reviews novel findings about the treatment of these conditions in HF.
Related Concept Videos
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Plant Hormones
Hormonal Regulation
Hormonal Regulation
Heart Failure VI: Adjunct Therapies

